Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Total Non-Current Liabilities (2017 - 2024)

CV Sciences' Total Non-Current Liabilities history spans 9 years, with the latest figure at $6.1 million for Q4 2024.

  • For Q4 2024, Total Non-Current Liabilities fell 0.97% year-over-year to $6.1 million; the TTM value through Dec 2024 reached $6.1 million, down 0.97%, while the annual FY2024 figure was $6.1 million, 0.97% down from the prior year.
  • Total Non-Current Liabilities for Q4 2024 was $6.1 million at CV Sciences, roughly flat from $6.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $23.7 million in Q2 2020 and bottomed at $6.0 million in Q1 2024.
  • The 4-year median for Total Non-Current Liabilities is $9.9 million (2022), against an average of $12.8 million.
  • The largest annual shift saw Total Non-Current Liabilities skyrocketed 36.51% in 2020 before it plummeted 54.18% in 2023.
  • A 4-year view of Total Non-Current Liabilities shows it stood at $19.4 million in 2020, then plummeted by 30.39% to $13.5 million in 2022, then tumbled by 54.18% to $6.2 million in 2023, then fell by 0.97% to $6.1 million in 2024.
  • Per Business Quant, the three most recent readings for CVSI's Total Non-Current Liabilities are $6.1 million (Q4 2024), $6.2 million (Q3 2024), and $6.3 million (Q2 2024).